Our early studies demonstrate that losartan decreased portal pressure and ameliorated hyperdynamic circulation on bile duct-ligated cirrhotic rats with portal hypertension [24] and involvement of the HIF-1α and Wnt/β-catenin pathways on fatty liver graft with ischemia/reperfusion injury [25]. Here, HIF1A is linked to liver disorder.